We are live on
!
Find out more
MBA
Maple-Brown Abbott Portfolio holdings
AUM
$1.47B
1-Year Est. Return
27.26%
This Fund
S&P 500
This Quarter
Est. Return
+1.11%
1 Year Est. Return
+27.26%
3 Year Est. Return
+7.92%
5 Year Est. Return
+61.22%
10 Year Est. Return
+88.77%
AUM
$971M
AUM Growth
+$153M
(+19%)
Cap. Flow
+$146M
Cap. Flow
% of AUM
14.99%
Top 10 Holdings %
Top 10 Hldgs %
74.46%
Holding
19
New
1
Increased
14
Reduced
2
Closed
–
Top Buys
| 1 |
Kinder Morgan
KMI
|
+$34M |
| 2 |
NiSource
NI
|
+$28.3M |
| 3 |
Crown Castle
CCI
|
+$11.9M |
| 4 |
Sempra
SRE
|
+$10.4M |
| 5 |
EEQ
Enbridge Energy Management Llc
EEQ
|
+$10.4M |
Top Sells
| 1 |
PG&E
PCG
|
+$1.83M |
| 2 |
JOBS
51job Inc
JOBS
|
+$19.8K |
Sector Composition
| 1 | Utilities | 35.35% |
| 2 | Energy | 16.11% |
| 3 | Real Estate | 12.39% |
| 4 | Communication Services | 9.85% |
| 5 | Technology | 4.93% |
Similar funds
AP
CC
TW
PAME
UH
SIA
MW
ST
Maple-Brown Abbott's Q2 2017 Portfolio in Review
As of Q2 2017, Maple-Brown Abbott held 19 positions worth $971M, up 19% from $818M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Maple-Brown Abbott deployed $146M of net new capital in Q2 2017, opening 1 new position and adding to 14 existing holdings. Its largest new stake was Williams Companies: 239,900 shares worth $7.26M.
By sector, the portfolio is most concentrated in Utilities at 35% of assets, up from 34% a quarter earlier, followed by Energy and Real Estate.
On the sell side, the largest reduction was PG&E, an estimated $1.83M trimmed.
- Maple-Brown Abbott's largest Q2 2017 buy was Williams Companies: 239,900 shares worth $7.26M.
- Maple-Brown Abbott added most to Kinder Morgan in Q2 2017, an estimated $34M increase.
- Maple-Brown Abbott's biggest Q2 2017 reduction was PG&E, cutting an estimated $1.83M.
- Maple-Brown Abbott's ten largest holdings make up 74% of its $971M portfolio in Q2 2017.
- Maple-Brown Abbott opened 1 new position and closed 0 in Q2 2017.
- Maple-Brown Abbott's portfolio value rose 19% quarter-over-quarter to $971M.
Based on Maple-Brown Abbott's 13F filing for Q2 2017, filed 2 Aug 2017.